Revenue rose to $13.4 million from $12.6 million.
Analysts' estimates were not available.
The company maintained its top-line revenue growth outlook of at least 10% for the fiscal year 2022.
Price: 5.52, Change: -0.03, Percent Change: -0.54
|MiMedx Says Glass Lewis Recommends in Favor of Direc...|
|T2 Biosystems Says It Secured US Patent Covering Met...|
|TherapeuticsMD Gets FDA Approval for Supplemental Ne...|
|Deere Raises Fiscal 2022 Profit Outlook After Postin...|
|Covetrus Says it Gets Proposal From Clayton, Dubilie...|